Alkermes plc - Ordinary Shares (ALKS)
ALKS Stock Chart More Charts
ALKS Price/Volume Stats
| Current price | $46.85 |
| Prev. close | $46.36 |
| Day low | $45.59 |
| Day high | $46.89 |
| 50-day MA | $55.20 |
| 200-day MA | $53.61 |
| 52-week high | $71.22 |
| 52-week low | $41.15 |
| Volume | 1,942,100 |
| Avg. volume | 1,238,316 |
| Dividend yield | N/A |
| Market Cap | 7.26B |
ALKS Returns
| 1-mo | -22.33% |
| 3-mo | -17.85% |
| 6-mo | -7.37% |
| 1-year | -17.01% |
| 3-year | -24.07% |
| 5-year | 49.82% |
| YTD | -14.40% |
| 2017 | -1.53% |
| 2016 | -29.98% |
| 2015 | 35.55% |
| 2014 | 44.02% |
| 2013 | 119.55% |
Alkermes plc - Ordinary Shares (ALKS) Company Bio
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 and is based in Dublin, Ireland.
Loading social stream, please wait...